DOUGLAS RICHARD - 04 Jun 2024 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Issuer symbol
ALDX
Transactions as of
04 Jun 2024
Net transactions value
$0
Form type
4
Filing time
06 Jun 2024, 16:15:15 UTC
Previous filing
05 Jul 2023
Next filing
13 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +40,282 $0.000000 40,282 04 Jun 2024 Common Stock 40,282 $4.09 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +10,418 $0.000000 10,418 04 Jun 2024 Common Stock 10,418 $4.09 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +1,215 $0.000000 1,215 04 Jun 2024 Common Stock 1,215 $4.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.